Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factorT Demirer, C D Buckner, B Storer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemiaS Riddell, F R Appelbaum, C D Buckner, et al.
Bone Marrow Transplantation|May 1, 1996
High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancerT Demirer, C D Buckner, F R Appelbaum, et al.
Blood|October 1, 1996
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcomeW I Bensinger, C D Buckner, C Anasetti, et al.
The New England Journal of Medicine|March 20, 1986
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemiaR Storb, H J Deeg, J Whitehead, et al.
Blood|July 1, 1986
Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host diseaseR Storb, H J Deeg, V Farewell, et al.
Blood|May 1, 1989
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trialR Storb, H J Deeg, M Pepe, et al.
Blood|February 1, 1988
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trialsR Storb, H J Deeg, L Fisher, et al.
British Journal of Haematology|August 1, 1989
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trialR Storb, H J Deeg, M Pepe, et al.
Bone Marrow Transplantation|March 1, 1993
Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemiaK Schiffman, R Clift, F R Appelbaum, et al.
Pageof 6